# Efficacy of Tranexamic Acid and Epsilon-aminocaproic Acid in Reducing Bleeding and Transfusions in Cardiac Surgery

> **NCT02655653** · PHASE3 · COMPLETED · sponsor: **Montefiore Medical Center** · enrollment: 114 (actual)

## Conditions studied

- Bleeding

## Interventions

- **DRUG:** Epsilon-aminocaproic acid administered
- **DRUG:** Tranexamic Acid administered

## Key facts

- **NCT ID:** NCT02655653
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2010-10
- **Final completion:** 2015-10
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2020-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02655653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02655653, "Efficacy of Tranexamic Acid and Epsilon-aminocaproic Acid in Reducing Bleeding and Transfusions in Cardiac Surgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02655653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
